NEW YORK, July 28 (GenomeWeb News) - Gene Logic has signed a toxicogenomics services deal with Organon, the companies said today.
Under the eighteen-month deal, GeneLogic will provide ToxScreen and Mechanism of Toxicity reports to Organon in order to evaluate the safety and toxicity of its drug candidates. The companies did not disclose the financial terms of the deal.
Organon has been a subscriber to Gene Logic's GeneExpress database since December 2000.